Industry › Healthcare & Pharm

Press Releases

Led by Legend Capital, Macrolux Completes Nearly CNY100 million Series A Round

Feb 16, 2023 17:09 HKT/SGT

疫苗开发不断变化的全球格局：Novotech 和 Endpoints News 网络研讨会

Feb 16, 2023 08:00 HKT/SGT

疫苗開發不斷變化的全球格局：Novotech 和 Endpoints News 網絡研討會

Feb 16, 2023 08:00 HKT/SGT

백신 개발 발전의 글로벌 환경: 노보텍 및 엔드포인트 뉴스 웨비나

Feb 16, 2023 08:00 HKT/SGT

Innovation is the Key Benchmark, Focus on Four Healthcare Industry Sub-Sectors in 2023, Says Jafar Wang of Legend Capital

Feb 15, 2023 18:58 HKT/SGT

The Evolving Global Landscape in Vaccine Development: Novotech and Endpoints News Webinar

Feb 15, 2023 09:00 HKT/SGT

ONERHT Foundation together with Chui Huay Lim Club and Ee Hoe Hean Club raise close to S$500,000 to promote medical care and support for disadvantaged groups

Feb 14, 2023 18:00 JST

ONERHT Foundation together with Chui Huay Lim Club and Ee Hoe Hean Club raise close to S$500,000 to promote medical care and support for disadvantaged groups

Feb 14, 2023 17:00 HKT/SGT

欧康维视发布2022年度业绩盈利预喜

Feb 14, 2023 10:59 HKT/SGT

歐康維視發佈2022年度業績盈利預喜

Feb 14, 2023 10:58 HKT/SGT

Ocumension Therapeutics Issues Positive Profit Alert for 2022 Annual Results

Feb 14, 2023 10:57 HKT/SGT

医思健康与保诚香港达成战略合作

Feb 13, 2023 19:11 HKT/SGT

醫思健康與保誠香港達成戰略合作

Feb 13, 2023 19:10 HKT/SGT

EC Healthcare Announced Strategic Alliance with Prudential

Feb 13, 2023 19:09 HKT/SGT

Novotech 全球報告：亞太地區穩健的 1 期試驗增長

Feb 13, 2023 06:00 HKT/SGT

노보텍 글로벌 보고서: 아시아 태평양 지역에서 1단계 임상시험의 확고한 성장

Feb 13, 2023 06:00 HKT/SGT

Novotech 全球报告：亚太地区稳健的 1 期试验增长

Feb 13, 2023 06:00 HKT/SGT

First Patient in the US Dosed in a Global Multicentre Phase 3 Clinical Study of Bevacizumab for treatment of Ophthalmic Diseases

Feb 10, 2023 21:06 HKT/SGT

亿胜生物宣布贝伐珠单抗眼科适应症国际多中心III期临床研究完成美国首例患者给药

Feb 10, 2023 20:39 HKT/SGT

億勝生物宣佈貝伐珠單抗眼科適應症國際多中心III期臨床研究完成美國首例患者給藥

Feb 10, 2023 20:38 HKT/SGT